BDC Life Sciences Venture Fund
Canada
Investment Thesis
A $150M BDC fund (launched 2026) providing patient capital to early-stage Canadian life sciences companies — therapeutics and medical technologies — to move from the lab to the market. Seed and Series A.
Focus Areas
Investment Stage
SeedSeries A
Investment Signals
Check SizeC$12M
GeographyCanada-only
RoleBoth
Revenue Stagepre-revenue ok
Business Modelstherapeutics, medical devices/medtech
AUM & Sources
Est. C$150M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.